Logo image
Bioprinting ofin vitrotumor models for personalized cancer treatment: a review
Journal article   Peer reviewed

Bioprinting ofin vitrotumor models for personalized cancer treatment: a review

Shuangshuang Mao, Yuan Pang, Tiankun Liu, Yongchun Shao, Jianyu He, Huayu Yang, Yilei Mao and Wei Sun
Biofabrication, v 12(4)
01 Oct 2020
PMID: 32470967

Abstract

Engineering Engineering, Biomedical Materials Science Materials Science, Biomaterials Science & Technology Technology
Studying biological characteristics of tumors and evaluating the treatment effects require appropriatein vitrotumor models. However, the occurrence, progression, and migration of tumors involve spatiotemporal changes, cell-microenvironment and cell-cell interactions, and signal transmission in cells, which makes the construction ofin vitrotumor models extremely challenging. In the past few years, advances in biomaterials and tissue engineering methods, especially development of the bioprinting technology, have paved the way for innovative platform technologies forin vitrocancer research. Bioprinting can accurately control the distribution of cells, active molecules, and biomaterials. Furthermore, this technology recapitulates the key characteristics of the tumor microenvironment and constructsin vitrotumor models with bionic structures and physiological systems. These models can be used as robust platforms to study tumor initiation, interaction with the microenvironment, angiogenesis, motility and invasion, as well as intra- and extravasation. Bioprinted tumor models can also be used for high-throughput drug screening and validation and provide the possibility for personalized cancer treatment research. This review describes the basic characteristics of the tumor and its microenvironment and focuses on the importance and relevance of bioprinting technology in the construction of tumor models. Research progress in the bioprinting of monocellular, multicellular, and personalized tumor models is discussed, and comprehensive application of bioprinting in preclinical drug screening and innovative therapy is reviewed. Finally, we offer our perspective on the shortcomings of the existing models and explore new technologies to outline the direction of future development and application prospects of next-generation tumor models.

Metrics

5 Record Views
79 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Engineering, Biomedical
Materials Science, Biomaterials
Logo image